9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
41 hedge funds and large institutions have $23.9M invested in 9 Meters Biopharma in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 1 reducing their positions, and 3 closing their positions.
1,200% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 1
533% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 3
87% more call options, than puts
Call options by funds: $311K | Put options by funds: $166K
58% more funds holding
Funds holding: 26 → 41 (+15)
47% more capital invested
Capital invested by funds: $16.3M → $23.9M (+$7.59M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$559K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$143K |
| 3 |
Renaissance Technologies
New York
|
+$127K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$109K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$623K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$108K |
| 3 |
CWS
Cypress Wealth Services
Palm Desert,
California
|
-$6.06K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$449 |
NMTR Hedge Fund Activity: Q3 2020 in Review
41 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2020, worth a combined $23.9M — up 47% from $16.3M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new NMTR positions and 3 closed out — a net gain of 16 holders — while 13 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $559K. The largest seller was Granite Point Capital Management, exiting entirely with an estimated $623K sold.
- 41 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2020, up from 26 in Q2 2020.
- Funds reported $23.9M of 9 Meters Biopharma stock for Q3 2020, up 47% quarter-over-quarter.
- 19 funds opened new 9 Meters Biopharma positions in Q3 2020 and 3 closed out, a net change of +16 holders.
- The largest 9 Meters Biopharma buyer in Q3 2020 was Millennium Management, an estimated $559K added.
- The largest 9 Meters Biopharma seller in Q3 2020 was Granite Point Capital Management, an estimated $623K sold.
Based on aggregated 13F filings for Q3 2020.